Here is a very recent discussion between some highly regarded individuals within the ophthalmology space regarding the benefits of combining canaloplasty with a stent -- meaning that EYE may not necessarily have to compete with Glaukos and instead, will benefit from the success of iStent
Viscodilation in the Canal - Eyetube
Nova Eye Medical (EYE) Discussion, page-3
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
28.5¢ |
Change
-0.010(3.39%) |
Mkt cap ! $65.21M | |||
| Open | High | Low | Value | Volume |
| 29.5¢ | 30.0¢ | 28.0¢ | $180.6K | 627.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 129581 | 28.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.0¢ | 266245 | 6 |
View Market Depth
| Last trade - 15.13pm 21/05/2024 (20 minute delay) ? |
|
|||||
|
Last
28.5¢ |
Change
-0.010 ( 3.06 %) |
||||
| Open | High | Low | Volume | ||
| 30.0¢ | 30.0¢ | 27.5¢ | 427036 | ||
| Last updated 15.55pm 21/05/2024 ? | |||||
| EYE (ASX) Chart |